Lv1
30 积分 2026-05-19 加入
Dynamic Treatment Strategy of Chinese Medicine for Metastatic Colorectal Cancer Based on Machine Learning Algorithm
5小时前
已完结
SISAQOL-IMI consensus-based guidelines to design, analyse, interpret, and present patient-reported outcomes in cancer clinical trials
30天前
已完结
Patient-reported outcomes and time to symptomatic progression from PAPILLON: amivantamab plus chemotherapy vs chemotherapy as first-line treatment of EGFR exon 20 insertion-mutated advanced NSCLC
30天前
已完结
Relationships between clinician-confirmed symptomatic progression and change in patient-reported outcomes in NSCLC
1个月前
已完结
Assessing time to symptomatic progression, a patient-relevant efficacy endpoint, in the MARIPOSA study in non-small cell lung cancer
1个月前
已完结
Most common symptomatic adverse reactions of cancer treatments from US drug labels (2015-2021) to inform selection of patient-reported outcomes
1个月前
已完结
Importance of responder criteria for reporting health-related quality-of-life data in clinical trials for advanced cancer: recommendations of Common Sense Oncology and the European Organisation for Research and Treatment of Cancer
1个月前
已完结
Characteristics and prognostic impact of cancer cachexia defined by the Asian Working Group for Cachexia consensus in patients with curable gastric cancer
2个月前
已完结
Integrating Chinese herbal medicine in advanced lung cancer: A multicenter real-world study using target trial emulation
3个月前
已完结
皖公网安备34019202002308
